v3 Template
C

Cure Alzheimer's Fund

Healthcare ~1K employees
Founded
--
Employees (Est.)
~1K
62 leaders known
Total Funding
$50.1M
Funding Rounds
3
Last Funding
2025-09-26

About Cure Alzheimer's Fund

Cure Alzheimer's Fund is a non-profit organization dedicated to funding research with the highest probability of preventing, slowing, or reversing Alzheimer's disease. Founded by individuals frustrated with the slow pace of research, the organization applies a venture capital approach to accelerate research and make bold bets to eradicate the disease. Their Board of Directors and core donors cover overhead costs, ensuring that 100% of general donations support their research program.

Products & Services

Research Funding:Provides grants and funding for projects aimed at finding a cure for Alzheimer's disease, focusing on innovative and high-impact research.
Educational Resources:Offers information on Alzheimer's disease basics, including pathology, stages, symptoms, risk factors, genetics, diagnostics, treatments, and brain health strategies.
Research Consortia and Projects:Supports various research consortia and areas of focus such as the Alzheimer's Genome Project™, therapeutic strategies, drug discovery, and whole genome sequencing.

Specialties

Alzheimer's Disease Research Genomics and Whole Genome Sequencing Therapeutic Strategies and Drug Discovery Immune System and Neuroimmune Research Microbiome and Brain Health Pathological Pathways and Systems

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Donation
T: -
FT: Donation
A: 50000000
MR: -
FA: $50 million
FAN: 50000000
D: 2025-09-26
FD: 2025-09-26
1 investors
2 RT: Donation
T: -
FT: Donation
A: 8400
MR: -
FA: $8,400
FAN: 8400
D: 2023-05-25
FD: 2023-05-25
1 investors
3 RT: Donation
T: -
FT: Donation
A: 136000
MR: -
FA: more than $136,000
FAN: 136000
D: 2023-03-13
FD: 2023-03-13
1 investors
Donation Latest
2025-09-26
$50.0M
1 investor (Pro only)
Donation 2023-05-25
$8K
Donation 2023-03-13
$136K

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Carmela R. Abraham

Professor

N

Nicola Allen

Associate Professor, Salk Institute for Biological Studies

A

Ananth Annapragada

Associate Professor

S

Srdjan D. Antic

Associate Professor of Neuroscience

S

Steven E. Arnold

Professor of Neurology at Harvard Medical School; Translational Neurology Head and Managing Director of the Interdisciplinary Brain Center at Massachusetts General Hospital

D

Darren J. Baker

Associate Professor of Biochemistry and Molecular Biology, Assistant Professor of Pediatrics, Mayo Clinic

View 59 more team members with Pro

Unlock Full Team Directory

Recent News

Cure Alzheimer's Fund Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare
Company Size
~1K employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro